Alpha Layer / Signal Explorer

Signal Explorer

10-K · 10-Q · 8-K · last 6 months · ← back to feed

Clear ×
Sionna Therapeutics, Inc. SION

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Sep 14, 2026 8-K 12 signals fired
Other
Restructuring Charge Disclosed Fda Aligned Workforce Reduction Restructuring Plan Interim Data Positive Restructuring Initiated Equity Plan Board Approval Conditional On Shareholder Vote
Biotech Risk
Trial Endpoint Missed
Core
Clinical Trial Result Lead Asset Progress Secondary Endpoint Mentioned Combination Therapy Mentioned Indication Expansion
Aug 10, 2026 8-K 5 signals fired
Other
Interim Data Positive Fda Aligned Patient Retention High
Core
Clinical Trial Result Combination Therapy Mentioned
Aug 6, 2026 10-Q 23 signals fired · top 15
Other
Financing Activities Cash Flow Disclosure Depreciation Expense Composition Disclosure Cash Flow Statement Investing Activities Reimbursement Price Pressure Risk Liquidity Position Snapshot Disclosed Net Loss Reported Emerging Growth Company Status Disclosed Interim Data Positive Stock Option Intrinsic Value Disclosure Patient Retention High Ipo Or Capital Raising Completion Shares Outstanding Disclosure Geopolitical Risk Disclosure 2023 2024 Interest Income Year Over Year Comparison
Core
Clinical Trial Result
Aug 6, 2026 8-K 5 signals fired
Other
Net Loss Reported Liquidity Position Snapshot Disclosed Interim Data Positive Enrollment Ahead Of Schedule
Core
Clinical Trial Result
Jun 18, 2026 8-K 3 signals fired
Other
Auditor Appointment Ratification Classified Board Director Election Shares Outstanding Disclosure
May 12, 2026 10-Q 22 signals fired · top 15
Other
Financing Activities Cash Flow Disclosure Depreciation Expense Composition Disclosure Cash Flow Statement Investing Activities Liquidity Position Snapshot Disclosed Form S3 Shelf Registration Disclosure Net Loss Reported Ipo Or Capital Raising Completion Stock Option Intrinsic Value Disclosure Enrollment Ahead Of Schedule Shares Outstanding Disclosure Interest Income Year Over Year Comparison Market Volatility Risk Disclosure Interim Data Positive
Core
Regulatory Designation Only Indication Expansion
May 12, 2026 8-K 8 signals fired
Other
Net Loss Reported Liquidity Position Snapshot Disclosed Interim Data Positive Enrollment Ahead Of Schedule
Core
Indication Expansion Clinical Trial Result Lead Asset Progress Combination Therapy Mentioned